Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Muratet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Nuclear Medicine|September 1, 1996
Thymus accumulation of I-131 after therapeutic dose for thyroid carcinomaJ P Muratet, P Giraud
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinomaJ P Muratet, A Daver, J F Minier, et al.
Presse Medicale (Paris, France : 1983)|February 12, 1994
[Thyroid metastasis]A Bergère, A Lortholary, J P Muratet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinomaJ P Muratet, P Giraud, A Daver, et al.
Clinical Nuclear Medicine|May 16, 2001
False-positive suspicion of a thyroid metastatic lesion by In-111 pentetreotide uptake in a toxic nodular goiterM Gaci, O Morel, A M Sultan, et al.
Breast (Edinburgh, Scotland)|August 25, 2004
Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcificationsE Fondrinier, J P Muratet, E Anglade, et al.
Clinical Chemistry|February 1, 1996
Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodiesP Y Marquet, A Daver, R Sapin, et al.
Bulletin Du Cancer|February 10, 1999
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology]J Maublant, J P Vuillez, J N Talbot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]P Pommier, A Villers, A Bataillard, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|September 1, 1996
Thymus accumulation of I-131 after therapeutic dose for thyroid carcinomaJ P Muratet, P Giraud
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinomaJ P Muratet, A Daver, J F Minier, et al.
Presse Medicale (Paris, France : 1983)|February 12, 1994
[Thyroid metastasis]A Bergère, A Lortholary, J P Muratet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinomaJ P Muratet, P Giraud, A Daver, et al.
Clinical Nuclear Medicine|May 16, 2001
False-positive suspicion of a thyroid metastatic lesion by In-111 pentetreotide uptake in a toxic nodular goiterM Gaci, O Morel, A M Sultan, et al.
Breast (Edinburgh, Scotland)|August 25, 2004
Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcificationsE Fondrinier, J P Muratet, E Anglade, et al.
Clinical Chemistry|February 1, 1996
Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodiesP Y Marquet, A Daver, R Sapin, et al.
Bulletin Du Cancer|February 10, 1999
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology]J Maublant, J P Vuillez, J N Talbot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]P Pommier, A Villers, A Bataillard, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Pageof 2